Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers

NCT04670757 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CPL409116
DRUG: Placebo

Sponsor

Celon Pharma SA

Collaborators

[object Object]